Back to Results
First PageMeta Content
Pharmaceutical industry / Health / Antibiotice Iaşi / Economy of Romania / Nystatin / Iași / Good manufacturing practice / Bucharest Stock Exchange / Food and Drug Administration / Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy


ANNUAL REPORT
Add to Reading List

Document Date: 2011-07-17 17:00:00


Open Document

File Size: 1,92 MB

Share Result on Facebook

City

Paris / /

Company

Antibiotice Enterprise / Cphl Worldwide / Annual Report 2010 01- Company Profile Antibiotice / Bucharest Stock Exchange / Antibiotice SA / /

Continent

America / Asia / Europe / /

Country

Romania / Japan / Russia / United States / Australia / /

Event

Company Expansion / /

Facility

Tablet Plant / Chemical Factory / /

IndustryTerm

manufacturing lines / musculoskeletal and central nervous systems / analytical equipment / large pharmaceutical corporations producing innovatives / important products / pharmaceutical industry / laboratory-scale manufacturing equipment / pharmaceutical forms / manufacturing lines producing / line manufacturing / pharmaceutical market / manufacturing / active pharmaceutical ingredients / manufacturing plant / manufacturing line / medicinal products / manufacturing capabilities / manufacturing processes / manufacturing process / /

Organization

Management Board / National Agency for Medicines and Medical Devices / FDA / National Association of Exporters and Importers of Romania / European Union / Center for Drug Evaluation / Food and Drug Authority / Romanian Chamber of Commerce / /

Person

Ioan Nani / /

Position

President / manager / market Domestic market leader / Chief Executive Officer / Auditor / short introduction Domestic Profile Leading producer / Domestic market leader / producer / /

Product

Nystatin / /

PublishedMedium

Atlas / /

RadioStation

America 1 / America 12 / /

Region

Northern Africa / east Europe / Eastern Europe / Middle East / /

Technology

anti-infectives / /

SocialTag